Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction

被引:45
|
作者
Farwell, WR
Sesso, HD [1 ]
Buring, JE
Gaziano, JM
机构
[1] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Aging, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Prevent Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Ambulatorio Care & Prevent, Boston, MA 02115 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 96卷 / 08期
关键词
D O I
10.1016/j.amjcard.2005.06.044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low-density lipoprotein (LDL) cholesterol is the primary lipid parameter targeted to prevent myocardial infarction. Alternatively, non-high-density lipoprotein (HDL) cholesterol includes LDL cholesterol and other atherogenic particles but does not require a fasting sample. Non-HDL cholesterol and LDL cholesterol as predictors of first nonfatal myocardial infarction were compared in 303 patients and 297 controls matched for age, gender, and community within the Boston Area Health Study. Patients were white men or women aged <76 years living in the Boston area, without a history of myocardial infarction or angina pectoris, in whom symptoms of confirmed myocardial infarction began during the 24 hours before admission. After multivariate adjustment for coronary risk factors in unmatched analyses, the corresponding odds ratios (ORs) of a first nonfatal myocardial infarction for non-HDL cholesterol in the second, third, and fourth quartiles were 1.83 (95% confidence interval [CI] 1.07 to 3.14), 2.07 (95% CI 1.23 to 3.49), and 2.33 (95% CI 1.39 to 3.90) (p trend <0.01). For LDL cholesterol, the ORs were 1.10 (95% CI 0.67 to 1.81), 0.87 (95% CI 0.52 to 1.46), and 1.45 (95% CI 0.90 to 2.35) (p trend = 0.16). Including HDL cholesterol in the model increased the ORs and strengthened the test for a trend for LDL cholesterol, whereas the ORs were decreased and the test for a trend was weakened for non-HDL cholesterol. In conclusion, given that non-HDL cholesterol accounts for LDL cholesterol plus other atherogenic particles but does not require a fasting sample, this study suggests that non-HDL cholesterol may be at least as useful as LDL cholesterol to initially screen patients for risk of a first nonfatal myocardial infarction. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1129 / 1134
页数:6
相关论文
共 50 条
  • [1] Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
    Manoj Sigdel
    Binod Kumar Yadav
    Prajwal Gyawali
    Prashant Regmi
    Sushil Baral
    Shyam Raj Regmi
    Bharat Jha
    BMC Research Notes, 5 (1)
  • [2] Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol measurement in Familial Dysbetalipoproteinemia
    Heidemann, Britt E.
    Koopal, Charlotte
    Lennep, Jeanine E. Roeters van
    Stroes, Erik S.
    Riksen, Niels P.
    Mulder, Monique T.
    van Vark - van der Zee, Leonie C.
    Blackhurst, Dee M.
    Visseren, Frank L. J.
    Marais, A. David
    CLINICA CHIMICA ACTA, 2023, 539 : 114 - 121
  • [3] Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper
    Colivicchi, Furio
    Di Fusco, Stefania Angela
    Arca, Marcello
    Leggio, Massimo
    Caldarola, Pasquale
    Murrone, Adriano
    Valente, Serafina
    Urbinati, Stefano
    Roncon, Loris
    Amodeo, Vincenzo
    Aspromonte, Nadia
    Cipriani, Manlio
    Domenicucci, Stefano
    Francese, Giuseppina Maura
    Imazio, Massimo
    di Uccio, Fortunato Scotto
    Di Lenarda, Andrea
    Gulizia, Michele Massimo
    Gabrielli, Domenico
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (08) : 609 - 617
  • [4] Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care
    Bilgic, Selin
    Sniderman, Allan D.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (01) : 49 - 53
  • [5] Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement
    Contois, John H.
    Warnick, G. Russell
    Sniderman, Allan D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (04) : 264 - 272
  • [6] Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol
    Sniderman, Allan D.
    Islam, Shofiqul
    McQueen, Matthew
    Pencina, Michael
    Furberg, Curt D.
    Thanassoulis, George
    Yusuf, Salim
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (10):
  • [7] Fasting non-high-density lipoprotein cholesterol and low-density lipoprotein particle size
    Arisaka, Osamu
    Kariya, Katsura
    Ichikawa, Go
    JOURNAL OF PEDIATRICS, 2012, 160 (03): : 531 - 532
  • [8] Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study
    Wu, Jianwei
    Chen, Shengyun
    Liu, Liping
    Gao, Xiang
    Zhou, Yong
    Wang, Chunxue
    Zhang, Qian
    Wang, Anxin
    Hussain, Mohammed
    Sun, Baoying
    Wu, Shouling
    Zhao, Xingquan
    NEUROLOGICAL RESEARCH, 2013, 35 (05) : 505 - 511
  • [9] An alternative marker of low-density lipoprotein cholesterol in coronary artery disease: non-high-density lipoprotein cholesterol
    Ercan, Mujgan
    Oguz, Esra
    Yilmaz, Fatma Meric
    Bogdaycioglu, Nihal
    Unal, Kubranur
    Sahin, Deniz
    Uysal, Sema
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2015, 45 (01) : 153 - 158
  • [10] Discordance of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol with Severity of Coronary Artery Disease
    Castro, Iran
    Fontana Filho, Hugo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 114 (03) : 476 - 476